Get started
VanEck Pharmaceutical ETFVanEck Pharmaceutical ETFVanEck Pharmaceutical ETF

VanEck Pharmaceutical ETF

No trades
See on Supercharts
Overview Analysis
Holdings
News Ideas Discussions Technicals Seasonals Options

VanEck Pharmaceutical ETF holdings


As of July 10, 2025
Symbol
Weight %
Shares
Market value
L
LLYEli Lilly and Company
18.51%
‪‪139.10 K‬‬
‪‪109.98 M‬‬USD
J
JNJJohnson & Johnson
10.18%
‪‪383.42 K‬‬
‪‪60.46 M‬‬USD
N
NVSNovartis AG Sponsored ADR
7.66%
‪‪367.63 K‬‬
‪‪45.49 M‬‬USD
N
NVONovo Nordisk A/S Sponsored ADR Class B
7.65%
‪‪639.75 K‬‬
‪‪45.43 M‬‬USD
M
MRKMerck & Co., Inc.
6.11%
‪‪431.73 K‬‬
‪‪36.27 M‬‬USD
P
PFEPfizer Inc.
4.79%
‪‪1.10 M‬‬
‪‪28.48 M‬‬USD
A
ABBVAbbVie, Inc.
4.64%
‪‪141.20 K‬‬
‪‪27.53 M‬‬USD
M
MCKMcKesson Corporation
4.53%
‪‪37.68 K‬‬
‪‪26.92 M‬‬USD
S
SNYSanofi SA Sponsored ADR
4.52%
‪‪544.10 K‬‬
‪‪26.85 M‬‬USD
A
AZNAstraZeneca PLC Sponsored ADR
4.43%
‪‪366.72 K‬‬
‪‪26.33 M‬‬USD
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.